The 14th International Congress on Autoimmunity (ICA) was held at the Ljubljana Exhibition and Convention Centre, May 17th-20th in Ljubljana, Slovenia.
The recent Transplant Sessions brought together Werfen colleagues and partners for two dynamic days of collaboration, innovation, and strategic planning.

Riyadh, November 6, 2024 – The Werfen EEMEA Event in Riyadh hosted the 15th Advanced Hemostasis Seminar, a full-day event dedicated to exploring the latest advancements and challenges in the field of hemostasis.
In November 2024, with our estimated partner AFMS, the EEMEA Marketing and Scientific Team organized in Riyadh (KSA) the 2024 edition of the Scientific Seminars.
February has been a memorable month in terms of Werfen Participation in Scientific Events for Hemostasis.
The 18th Annual EAHAD Congress (European Association for Haemophilia and Allied Disorders) in Milan provided an excellent opportunity to explore the latest advancements in Hemophilia and Allied Disorders.
The 35th Regional ISBT Congress, our largest Transfusion International congress, is taking place in Milan from May 31 - June 4, 2025. Werfen is attending ISBT with a 90 sqm booth.
EFI is here again!
The 38th EFI Conference, our largest annual European Transplant conference, is taking place in Prague, Czech Republic, 14-17 May 2025.
The LabQuality Days 2025 congress in Helsinki was a resounding success, bringing together leading professionals in laboratory medicine and healthcare technology.
GTH has held a conference in Germany, Austria or Switzerland every year and has established itself as the world’s second largest specialist society in the field of thrombosis and haemostasis.
The new approach that Werfen is applying to the management of Promotional Marketing Material has been implemented from mid-May 2025.
Werfen has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents.

